Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

National tariffs for outpatient specialist and prosthetic care updated in Italy

21 Aug 2023

The Essential Levels of Care (LEA) document from 2017 is the document that defines the guaranteed basket of benefits for the Italian population. Annex 4 of the LEA document contains a fee-for-service list of outpatient specialist services (including IVD tests) guaranteed on the national level. Annex 5 of the LEA document contains the nationally-guaranteed medical aids and prostheses.

Although the LEA document was brought in 2017, the services did not have relevant national tariffs established. So far, the only national tariffs (used by the Regions as a reference for developing regional tariffs, which are actually used for reimbursement of services) were from 2012.

After the draft decree defining the reimbursement tariffs for the 2017 LEA catalog submitted to the State-Regions Conference in January 2022 was rejected, a new draft decree was presented in September 2022. Eventually, in April 2023, the Italian Ministry of Health announced that the State-Regions Conference approved the national tariffs for outpatient specialist care and prosthetic care.

However, with the Decree of the Ministry of Health, in agreement with the Ministry of Economy and Finance, dated 23 June and published in the Official Gazette on 4 August 2023, the tariffs for the 2017 LEA were updated. The new tariffs for outpatient specialist care will be applied to Annex 4 of the LEA document and enter into force in January 2024; the new tariffs for prosthetic care will be applied to Annex 5 and enter into force in April 2024.

See full details in Italian here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.